0 followers
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.
Xeris Pharmaceuticals
2 followers
Cosette Pharmaceuticals
1 follower
Bristol-Myers Squibb
250 followers
NYU Langone Health
23 followers
West Pharmaceutical Services
8 followers
Curia Global
6 followers
AbbVie
269 followers
Navitus Health
3 followers
Corcept Therapeutics
4 followers
Catalyst Pharmaceuticals
2 followers
Arthritis Knee Pain Centers
2 followers
Explore companies